CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. for Solar Elastosis

The current prevalence of solar elastosis is roughly 15% of all skin conditions; but it is still not a widely identified condition and its exact prevalence is unknown. A detailed prevalence study is needed to document the incidence, nature, and severity of solar elastosis; to find its aetiology and treatment; and to formulate public awareness and prevention programmes.

The appearance of solar elastosis in childhood and early adulthood is characterized by a gradual onset and progression of pale skin from the back of the arms and hands to the cheeks, and a gradual change in height. This change in skin pigmentation from red to pale can appear in just a few days.\n

In this small series, the solar elastosis condition was diagnosed only in patients who had light-mediated damage to the skin from the prolonged exposure to sunlight, a process that may be triggered by sunburn, sun-induced inflammation and photoaging through photo-damage and chronic inflammation in individuals of Northern European descent. In order to avoid excessive photobiological damage, sunlight and sunlight-induced inflammation should be used wisely to protect the skin from solar elastosis.

Solar elastosis is a well known skin anomaly characterized by hard pigmented papules in sun-exposed areas resulting from reduced elasticity and diminished pigmentation of the skin in response to UVA radiation. It may be associated with the Wnt and Toll-like receptor pathways and the immune system.

Solar elastosis was seen to heal after solar elastosis treatment in this small series. Solar elastosis has the potential to be a useful treatment for those with solar elastosis.

There are many treatments available for solar elastosis, such as protective glasses, sunscreen, cryotherapy (cooling with liquid nitrogen gas or ice cream), or surgical treatments, such as laser surgery or dermabrasion.

Sun-Protection Education can prevent sunburn during outdoor activities and decrease chronic sun exposure over a lifetime. However, it is still uncertain what the average age is for Solar Elastosis in the United States. Please see the "Find a Clinical Trial" section above to find the appropriate clinical trial for your situation.

Current clinical research results in the use of a handpiece based on the technology of solar elastosis for transoral (head and neck) therapy of diseases like cancers and vascular diseases. The data of these ongoing trials should be evaluated at the beginning of the first treatments. In the further development, the use of this type of handpiece should also be investigated in relation to the use of the same device in conjunction with other conventional therapeutic modalities.

Clinicians may be unable to identify an intraoperatively used handpiece based solely upon the wavelength of the lamp. Careful use of the Clear Plus handpiece in these settings may help ensure the correct wavelengths of the handpiece are used to prevent excessive blood loss. However, using 2 LED handpieces is the best procedure for ensuring that proper wavelengths are being used and thus, preventing excessive blood loss.

The solar elastosis seen in the present case does not seem to coincide with any other type of solar elastosis described by the authors before and we therefore question whether there are any genetic influences on the development of solar elastosis.

When comparing the two handpieces, we found that the clear + brilliant touch(r) 1440-nm handpiece generated fewer complaints of dryness and itching or irritation than the 1927-nm handpiece. Skin changes, including lightening, and pigment changes were also less common with the clear + brilliant touch(r) 1400-nm handpiece, compared with the 1927-nm handpiece, although they did occur.